首页> 外文期刊>Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society >Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.
【24h】

Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.

机译:使用VP22 DNA疫苗载体增强树突状细胞对抗原的获取以及MHC II类限制的抗原决定簇呈递给CD4 + T细胞,该载体可促进初始转染后细胞间的扩散。

获取原文
获取原文并翻译 | 示例
           

摘要

Induction of immune responses against microbial antigens using DNA is an attractive strategy to mimic the immunity induced by live vaccines. Although DNA vaccines are efficacious in murine models, the requirement for multiple immunizations using high doses in outbred animals and humans has hindered deployment. This requirement is, in part, a result of poor vaccine spreading and suboptimal DC transfection efficiency. Incorporation of a signal that directs intercellular spreading of a DNA-encoded antigen is proposed to mimic live vaccine spreading and increase dendritic cell (DC) presentation. Bovine herpes virus 1 tegument protein, BVP22, is capable of trafficking to surrounding cells. To test the hypothesis that BVP22 enhances spreading and antigen presentation to CD4+ T cells, a DNA construct containing BVP22, fused in-frame to a sequence encoding a T cell epitope of Anaplasma marginale, was generated. A construct with reversed BVP22 sequence served as a negative control. Immunocytometric analysis of transfected primary keratinocytes, human embryonic kidney 293, COS-7, and Chinese hamster ovary cells showed that BVP22 enhanced intercellular spreading by > or = 150-fold. Flow cytometric analysis of antigen-presenting cells (APCs) positively selected from cocultures of transfected cells and APCs showed that 5% of test APCs were antigen-positive, compared with 0.6% of control APCs. Antigen-specific CD4+ T cell proliferation demonstrated that BVP22 enhanced DC antigen presentation by > or = 20-fold. This first report of the ability of BVP22 to increase DNA-encoded antigen acquisition by DCs and macrophages, with subsequent enhancement of major histocompatibility complex class II-restricted CD4+ T cell responses, supports incorporating a spreading motif in a DNA vaccine to target CD4+ T cell-dependent immunity in outbred animals.
机译:使用DNA诱导针对微生物抗原的免疫反应是模仿活疫苗诱导的免疫力的一种有吸引力的策略。尽管DNA疫苗在鼠模型中是有效的,但对近交动物和人类使用高剂量进行多次免疫的要求阻碍了其部署。该要求部分是由于疫苗传播差和DC转染效率欠佳所致。提出引入指导DNA编码抗原的细胞间扩散的信号以模拟活疫苗扩散并增加树突状细胞(DC)呈递。牛疱疹病毒1皮膜蛋白BVP22能够转运到周围细胞。为了检验BVP22增强向CD4 + T细胞的扩散和抗原呈递的假说,产生了含有BVP22的DNA构建体,该DNA构建体符合读框地融合到编码无性无浆膜T细胞表位的序列上。具有反向BVP22序列的构建体用作阴性对照。对转染的原代角质形成细胞,人类胚胎肾脏293,COS-7和中国仓鼠卵巢细胞的免疫细胞分析表明,BVP22增强了细胞间扩散,其作用范围为>或= 150倍。从转染细胞和APC的共培养物中阳性选择的抗原呈递细胞(APC)的流式细胞仪分析表明,测试的APC中有5%为抗原阳性,而对照APC为0.6%。抗原特异性CD4 + T细胞增殖表明BVP22增强DC抗原呈递>或= 20倍。 BVP22增加DC和巨噬细胞对DNA编码抗原的捕获能力以及随后对主要组织相容性复合物II类限制性CD4 + T细胞应答的增强的能力的第一份报告支持将扩散基序掺入DNA疫苗中以靶向CD4 + T细胞体动物的免疫依赖性免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号